trending Market Intelligence /marketintelligence/en/news-insights/trending/_SslW3NIm4CrnzKEaX-Exg2 content esgSubNav
In This List

Ritter Pharmaceuticals falls out of Nasdaq compliance

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Ritter Pharmaceuticals falls out of Nasdaq compliance

Ritter Pharmaceuticals Inc. fell out of compliance with Nasdaq's $1 minimum bid price listing rule.

The Los Angeles-based developer of drugs to treat gastrointestinal diseases has until June 24, 2019, to regain compliance, with a possibility for extension.

The company plans to evaluate available options to address the deficiency and regain compliance with the rule, the company said in a filing.